11/16
08:48 am
anab
Broker Revenue Forecasts For AnaptysBio, Inc. (NASDAQ:ANAB) Are Surging Higher [Yahoo! Finance]
Medium
Report
Broker Revenue Forecasts For AnaptysBio, Inc. (NASDAQ:ANAB) Are Surging Higher [Yahoo! Finance]
11/14
06:29 pm
anab
AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $42.00 price target on the stock.
Medium
Report
AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $42.00 price target on the stock.
11/12
10:45 am
anab
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $75.00 to $66.00. They now have an "overweight" rating on the stock.
Low
Report
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $75.00 to $66.00. They now have an "overweight" rating on the stock.
11/7
07:10 am
anab
AnaptysBio Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
AnaptysBio Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/6
02:10 pm
anab
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at HC Wainwright from $55.00 to $52.00. They now have a "buy" rating on the stock.
Low
Report
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at HC Wainwright from $55.00 to $52.00. They now have a "buy" rating on the stock.
11/6
10:28 am
anab
AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $42.00 price target on the stock.
Low
Report
AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $42.00 price target on the stock.
11/5
04:15 pm
anab
Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update
11/5
04:15 pm
anab
Anaptys Announces Participation in November and December Investor Conferences
Medium
Report
Anaptys Announces Participation in November and December Investor Conferences
10/31
08:35 am
anab
AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
Medium
Report
AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
10/30
10:08 am
anab
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at UBS Group AG from $23.00 to $33.00. They now have a "neutral" rating on the stock.
Medium
Report
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at UBS Group AG from $23.00 to $33.00. They now have a "neutral" rating on the stock.
10/21
02:22 pm
anab
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at Guggenheim from $75.00 to $90.00. They now have a "buy" rating on the stock.
Low
Report
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at Guggenheim from $75.00 to $90.00. They now have a "buy" rating on the stock.
9/26
10:15 am
anab
AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $42.00 price target on the stock.
Low
Report
AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $42.00 price target on the stock.
8/29
09:15 am
anab
Anaptys Announces Participation in September Investor Conferences
Low
Report
Anaptys Announces Participation in September Investor Conferences